APA (7th ed.) Citation

Wassarman, D. R., Pfaff, P., Paulo, J. A., Gygi, S. P., Shokat, K. M., & Kranzusch, P. J. (2025). Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity. Science, 389(6767), 1347. https://doi.org/10.1126/science.adx6053

Chicago Style (17th ed.) Citation

Wassarman, Douglas R., Patrick Pfaff, Joao A. Paulo, Steven P. Gygi, Kevan M. Shokat, and Philip J. Kranzusch. "Deazaguanylation Is a Nucleobase-protein Conjugation Required for Type IV CBASS Immunity." Science 389, no. 6767 (2025): 1347. https://doi.org/10.1126/science.adx6053.

MLA (9th ed.) Citation

Wassarman, Douglas R., et al. "Deazaguanylation Is a Nucleobase-protein Conjugation Required for Type IV CBASS Immunity." Science, vol. 389, no. 6767, 2025, p. 1347, https://doi.org/10.1126/science.adx6053.